WATSON PHARMACEUTICALS, INC., as Issuer and Wells Fargo Bank, National Association, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of August 24, 2009 to the Indenture dated as of August 24, 2009 5.000% Senior Notes due 2014 6.125% Senior Notes due 2019Watson Pharmaceuticals Inc • August 24th, 2009 • Pharmaceutical preparations • New York
SUPPLEMENTAL INDENTURE (this “First Supplemental Indenture”), dated as of August 24, 2009, between WATSON PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee (the “Trustee”).
WATSON PHARMACEUTICALS, INC. $450,000,000 5.000% Notes due 2014 $400,000,000 6.125% Notes due 2019 UNDERWRITING AGREEMENT AUGUST 18, 2009 Banc of America Securities LLC and Barclays Capital Inc.Underwriting Agreement • August 24th, 2009 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
BANC OF AMERICA SECURITIES LLC BARCLAYS CAPITAL INC. As Representatives of the several Underwriters c/o BANC OF AMERICA SECURITIES LLC One Bryant Park New York, NY 10036
